SEARCH RESULT

Total Matching Records found : 1115

Pranab banks on indirect tax hike-Ashok Dasgupta

Token relief to individual taxpayers will cost the exchequer Rs. 4,500 crore In a “pragmatic and domestic growth-oriented” budgetary exercise aimed at shoring up investor confidence and investment, Union Finance Minister Pranab Mukherjee on Friday sought to tap indirect taxes, especially service tax, to rake in an additional Rs. 45,940 crore into his kitty. Presenting the budget for 2012-13 in Parliament, Mr. Mukherjee provided a token relief to individual taxpayers that will cost...

More »

A welcome rollback

-The Business Standard Cotton export ban was an example of poor policy The government’s sudden move to ban cotton exports – rolled back in less than a week following anger from cotton farmers and adverse political fallout — reflects very poorly on its policy management. The commerce ministry clamped down on exports without clear logic; prior consultations with other ministries concerned were also cursory or non-existent. Unsurprisingly, most players in the cotton...

More »

Natco Pharma bags licence to sell Bayer's cancer drug Nexavar

-The Economic Times The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany's Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry's anxiety over the use of the controversial compulsory licensing provision.  The outgoing patent controller of India, PH Kurian, on Monday granted the country's first compulsory licence to...

More »

Natco gets India’s first compulsory licence-CH Unnikrishnan

In a landmark decision, India’s intellectual property office on Monday allowed Hyderabad-based Natco Pharma Ltd to make and sell a copycat version of German drug maker Bayer AG’s patented cancer treatment Nexavar. It’s the first time that an Indian company has been granted the so-called compulsory licence to market a generic version of a patented drug. The drug, patented by Bayer in India in 2008, is used in the treatment of...

More »

The time is not ripe

-The Hindustan Times The UPA’s record of policy flip-flops endures. The latest instance is a ban on exports of cotton that seems headed for revocation less than a week after it was announced. The commerce ministry’s line that India has exported more cotton this season than it can afford to without hurting consumption at home does not wash with partners of the ruling alliance or with the political bosses of cotton...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close